Antineoplastic Agents, Immunological [protinádorové látky imunologicky aktivní]
- Terms
-
monoklonální protilátky protinádorové
protinádorové mAb
protinádorové monoklonální protilátky
-
Antineoplastic MAbs
Antineoplastics, Monoclonal Antibodies
Antineoplastics, Monoclonal Antibody
MAbs, Antineoplastic
Monoclonal Antibodies, Antineoplastic
Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS.
- DUI
- D000074322 MeSH Browser
- CUI
- M000626416
- Previous indexing
- Antibodies, Monoclonal (1984-2017); Antineoplastic Agents (1986-2017)
- History note
- 2018
- Public note
- 2018
Allowable subheadings
- AD
- administration & dosage 94
- AE
- adverse effects 81
- AN
- analysis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification 27
- EC
- economics 7
- HI
- history 1
- IM
- immunology 5
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 5
- PD
- pharmacology 71
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 299
- TO
- toxicity 1
- UR
- urine